

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.55598929 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.55598929 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.31744326 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.31744326 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.91915363 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.76103434 |
| 7 | glyoxylate metabolic process (GO:0046487) | 5.45377351 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.34829745 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.34829745 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.34829745 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.34079810 |
| 12 | cysteine metabolic process (GO:0006534) | 5.24084752 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19422568 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.16444742 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.13784453 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.11077856 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.06143247 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.98908007 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.88766713 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85011386 |
| 21 | urea metabolic process (GO:0019627) | 4.81997641 |
| 22 | urea cycle (GO:0000050) | 4.81997641 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.79183650 |
| 24 | lysine catabolic process (GO:0006554) | 4.71294793 |
| 25 | lysine metabolic process (GO:0006553) | 4.71294793 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.64647442 |
| 27 | protein carboxylation (GO:0018214) | 4.64647442 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.54625604 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.54292227 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.53818225 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 4.51105981 |
| 32 | drug catabolic process (GO:0042737) | 4.50271223 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.50197764 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.47312460 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.45801761 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.45648464 |
| 37 | bile acid metabolic process (GO:0008206) | 4.45640950 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.43931117 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.43706838 |
| 40 | negative regulation of cell killing (GO:0031342) | 4.43706838 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.43095411 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 4.41660795 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.36586054 |
| 44 | regulation of protein activation cascade (GO:2000257) | 4.33725318 |
| 45 | detection of other organism (GO:0098543) | 4.30891554 |
| 46 | drug transmembrane transport (GO:0006855) | 4.30439901 |
| 47 | angiotensin maturation (GO:0002003) | 4.29019265 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.28561800 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.28561800 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.28061152 |
| 51 | phospholipid efflux (GO:0033700) | 4.27773138 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.24780719 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.24780719 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.24780719 |
| 55 | positive regulation by symbiont of host defense response (GO:0052509) | 4.24147128 |
| 56 | modulation by symbiont of host defense response (GO:0052031) | 4.24147128 |
| 57 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.24147128 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.24147128 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.24147128 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 4.24147128 |
| 61 | regulation of fibrinolysis (GO:0051917) | 4.23657181 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.14839222 |
| 63 | cellular glucuronidation (GO:0052695) | 4.11706201 |
| 64 | urate metabolic process (GO:0046415) | 4.11386706 |
| 65 | detection of bacterium (GO:0016045) | 4.11050927 |
| 66 | regulation of complement activation (GO:0030449) | 4.10947827 |
| 67 | tyrosine metabolic process (GO:0006570) | 4.04946393 |
| 68 | alpha-amino acid catabolic process (GO:1901606) | 4.04801964 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 4.04597894 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.99803423 |
| 71 | triglyceride homeostasis (GO:0070328) | 3.97917185 |
| 72 | acylglycerol homeostasis (GO:0055090) | 3.97917185 |
| 73 | ethanol oxidation (GO:0006069) | 3.97272899 |
| 74 | exogenous drug catabolic process (GO:0042738) | 3.96954418 |
| 75 | cholesterol efflux (GO:0033344) | 3.91052568 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.90067938 |
| 77 | glutamate metabolic process (GO:0006536) | 3.88842370 |
| 78 | bile acid and bile salt transport (GO:0015721) | 3.87834119 |
| 79 | detection of external biotic stimulus (GO:0098581) | 3.84240422 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 3.83871231 |
| 81 | flavonoid metabolic process (GO:0009812) | 3.82695953 |
| 82 | glucuronate metabolic process (GO:0019585) | 3.79661273 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.79661273 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 3.75963916 |
| 85 | regulation of cholesterol homeostasis (GO:2000188) | 3.74977888 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.74001301 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.73299791 |
| 88 | serine family amino acid metabolic process (GO:0009069) | 3.73018581 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 3.71781682 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71130055 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71130055 |
| 92 | coenzyme catabolic process (GO:0009109) | 3.68297990 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65250107 |
| 94 | epoxygenase P450 pathway (GO:0019373) | 3.64446298 |
| 95 | amine catabolic process (GO:0009310) | 3.63704116 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 3.63704116 |
| 97 | response to peptidoglycan (GO:0032494) | 3.63480355 |
| 98 | drug transport (GO:0015893) | 3.63040621 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.62242018 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 3.62039084 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.61729263 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.60883060 |
| 103 | ketone body metabolic process (GO:1902224) | 3.60056547 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.59419262 |
| 105 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.59011500 |
| 106 | fatty acid beta-oxidation (GO:0006635) | 3.58564465 |
| 107 | sterol homeostasis (GO:0055092) | 3.58555919 |
| 108 | fatty acid oxidation (GO:0019395) | 3.54379953 |
| 109 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53096528 |
| 110 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.52185593 |
| 111 | lipid oxidation (GO:0034440) | 3.50107843 |
| 112 | organic acid catabolic process (GO:0016054) | 3.49266680 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.49266680 |
| 114 | acetyl-CoA metabolic process (GO:0006084) | 3.49158545 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 3.47841999 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.46862683 |
| 117 | carnitine metabolic process (GO:0009437) | 3.45637857 |
| 118 | monocarboxylic acid catabolic process (GO:0072329) | 3.43411059 |
| 119 | lipoprotein transport (GO:0042953) | 3.43119354 |
| 120 | serine family amino acid biosynthetic process (GO:0009070) | 3.42820130 |
| 121 | cellular extravasation (GO:0045123) | 3.42809752 |
| 122 | glycine metabolic process (GO:0006544) | 3.42162241 |
| 123 | aspartate family amino acid catabolic process (GO:0009068) | 3.41333969 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.41093051 |
| 125 | lipoprotein metabolic process (GO:0042157) | 3.39781459 |
| 126 | fatty acid catabolic process (GO:0009062) | 3.39336914 |
| 127 | drug metabolic process (GO:0017144) | 3.37893024 |
| 128 | detection of biotic stimulus (GO:0009595) | 3.37447818 |
| 129 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.36518824 |
| 130 | regulation of gamma-delta T cell activation (GO:0046643) | 3.33693024 |
| 131 | neutrophil activation (GO:0042119) | 3.30776892 |
| 132 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20364027 |
| 133 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20089085 |
| 134 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15767888 |
| 135 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.14734184 |
| 136 | microglial cell activation (GO:0001774) | 3.11751563 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 3.05006565 |
| 138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00863359 |
| 139 | regulation of cellular extravasation (GO:0002691) | 3.00792985 |
| 140 | respiratory burst (GO:0045730) | 2.99807276 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99764600 |
| 142 | granulocyte activation (GO:0036230) | 2.93797812 |
| 143 | negative regulation of interleukin-12 production (GO:0032695) | 2.93294535 |
| 144 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85934695 |
| 145 | response to host immune response (GO:0052572) | 2.85681829 |
| 146 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85681829 |
| 147 | intestinal absorption (GO:0050892) | 2.83121199 |
| 148 | myeloid cell activation involved in immune response (GO:0002275) | 2.80419147 |
| 149 | macrophage activation (GO:0042116) | 2.80293005 |
| 150 | response to interleukin-15 (GO:0070672) | 2.79588231 |
| 151 | regulation of leukocyte degranulation (GO:0043300) | 2.77679852 |
| 152 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76579137 |
| 153 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74399563 |
| 154 | leukotriene metabolic process (GO:0006691) | 2.73869366 |
| 155 | B cell mediated immunity (GO:0019724) | 2.73813556 |
| 156 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72979604 |
| 157 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.71120285 |
| 158 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.70503878 |
| 159 | peptide catabolic process (GO:0043171) | 2.69666999 |
| 160 | positive regulation of B cell differentiation (GO:0045579) | 2.69357892 |
| 161 | leukocyte aggregation (GO:0070486) | 2.65574008 |
| 162 | positive regulation of mast cell activation (GO:0033005) | 2.64768159 |
| 163 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64588924 |
| 164 | response to host (GO:0075136) | 2.64588924 |
| 165 | response to host defenses (GO:0052200) | 2.64588924 |
| 166 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64521015 |
| 167 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63769479 |
| 168 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62281195 |
| 169 | B cell receptor signaling pathway (GO:0050853) | 2.60678414 |
| 170 | neutrophil mediated immunity (GO:0002446) | 2.60412274 |
| 171 | dendritic cell chemotaxis (GO:0002407) | 2.59810302 |
| 172 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59586299 |
| 173 | dendritic cell migration (GO:0036336) | 2.57574440 |
| 174 | regulation of mast cell activation (GO:0033003) | 2.57209492 |
| 175 | regulation of antigen processing and presentation (GO:0002577) | 2.56210240 |
| 176 | regulation of tolerance induction (GO:0002643) | 2.56192286 |
| 177 | glycosphingolipid catabolic process (GO:0046479) | 2.55976339 |
| 178 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54138619 |
| 179 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.52257746 |
| 180 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.51614987 |
| 181 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.50938056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.26635780 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.31968848 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76857244 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.51233501 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82015281 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.41325458 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.10002237 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.87674621 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45716208 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.19714569 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.09071560 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99105003 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80286796 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61141341 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45659032 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.42559587 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.33847590 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.21716740 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.15193950 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09046024 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05547572 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03766948 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02703283 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00112898 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0030916 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98040267 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96420586 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95175377 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88948870 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87769025 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.85731576 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83235804 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82450530 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80532733 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.78996227 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73985443 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73494082 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73212024 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67745253 |
| 40 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64970233 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.63755153 |
| 42 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.58287570 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57287470 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.53860296 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51123118 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48654801 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48484184 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47608077 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46934414 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46714520 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46682287 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43007467 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42934171 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40766470 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40223485 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38619849 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.38528516 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38242205 |
| 59 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36237994 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35854364 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35795533 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34251725 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31005189 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26584498 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25984270 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25698260 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22022437 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21801864 |
| 69 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.20631096 |
| 70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20603596 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19647794 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18858777 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15857906 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14957314 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13552938 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11135408 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08548933 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07921388 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06012892 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05781646 |
| 81 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04609744 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04530948 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02770926 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01001785 |
| 85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99153944 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97893224 |
| 87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95390110 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93229586 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93131340 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93101423 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93056787 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92466247 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92302142 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91546547 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91459777 |
| 96 | MAF_26560356_Chip-Seq_TH2_Human | 0.91260114 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90366014 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89899306 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88830584 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87868783 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87868783 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85346977 |
| 103 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83807749 |
| 104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83780798 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83653068 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81975142 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81184495 |
| 108 | MYC_22102868_ChIP-Seq_BL_Human | 0.79897686 |
| 109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76583735 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74780428 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74636551 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73840254 |
| 113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.73449319 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72849597 |
| 115 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.72705805 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72047779 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70797884 |
| 118 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70033684 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.69569787 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69426549 |
| 121 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.68296138 |
| 122 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.67185178 |
| 123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66949904 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65969677 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65752888 |
| 126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65106453 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64981708 |
| 128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64652158 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.64078363 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.63366051 |
| 131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62656663 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62614680 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.60560837 |
| 134 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59501161 |
| 135 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59486836 |
| 136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59370238 |
| 137 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59151018 |
| 138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.59083733 |
| 139 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.57691135 |
| 140 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.57264217 |
| 141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56478552 |
| 142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56463662 |
| 143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.56326565 |
| 144 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54508237 |
| 145 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.54505486 |
| 146 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.54505486 |
| 147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54351846 |
| 148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.53654300 |
| 149 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.52665285 |
| 150 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52005244 |
| 151 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.51979581 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.51574611 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51184228 |
| 154 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50824849 |
| 155 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.50758747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.59005148 |
| 2 | MP0005360_urolithiasis | 7.42817253 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.54107067 |
| 4 | MP0005365_abnormal_bile_salt | 5.27745999 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.85010337 |
| 6 | MP0003252_abnormal_bile_duct | 3.72088208 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.53222367 |
| 8 | MP0009840_abnormal_foam_cell | 3.49791711 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.26775469 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.05729310 |
| 11 | MP0005332_abnormal_amino_acid | 2.91480343 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.75687110 |
| 13 | MP0005083_abnormal_biliary_tract | 2.62738828 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.58534957 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.50471570 |
| 16 | MP0003195_calcinosis | 2.46236406 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.38830543 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.29018326 |
| 19 | MP0001800_abnormal_humoral_immune | 2.14338695 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.10242838 |
| 21 | MP0005671_abnormal_response_to | 2.07639694 |
| 22 | MP0000685_abnormal_immune_system | 2.04112269 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.02791725 |
| 24 | MP0005387_immune_system_phenotype | 2.02618669 |
| 25 | MP0001790_abnormal_immune_system | 2.02618669 |
| 26 | MP0000609_abnormal_liver_physiology | 2.00434764 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.94895245 |
| 28 | MP0002723_abnormal_immune_serum | 1.92226570 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.85641671 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.81757187 |
| 31 | MP0001819_abnormal_immune_cell | 1.81001654 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.78587511 |
| 33 | MP0003866_abnormal_defecation | 1.77632151 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.72718266 |
| 35 | MP0002132_abnormal_respiratory_system | 1.69597982 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63686412 |
| 37 | MP0004147_increased_porphyrin_level | 1.60578670 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.59299341 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.55019735 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.48668246 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.47453549 |
| 42 | MP0005451_abnormal_body_composition | 1.42056908 |
| 43 | MP0002405_respiratory_system_inflammati | 1.41186253 |
| 44 | MP0003868_abnormal_feces_composition | 1.41089939 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.37551411 |
| 46 | MP0000716_abnormal_immune_system | 1.36979543 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.34139422 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.34113775 |
| 49 | MP0003186_abnormal_redox_activity | 1.33346472 |
| 50 | MP0001764_abnormal_homeostasis | 1.33268944 |
| 51 | MP0002398_abnormal_bone_marrow | 1.30676391 |
| 52 | MP0000604_amyloidosis | 1.29213682 |
| 53 | MP0008260_abnormal_autophagy | 1.25517274 |
| 54 | MP0009764_decreased_sensitivity_to | 1.23886255 |
| 55 | MP0002254_reproductive_system_inflammat | 1.19484283 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 1.19319481 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.18847022 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.18847022 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.16986659 |
| 60 | MP0000858_altered_metastatic_potential | 1.15458805 |
| 61 | MP0004883_abnormal_blood_vessel | 1.14699009 |
| 62 | MP0002722_abnormal_immune_system | 1.13627736 |
| 63 | MP0002429_abnormal_blood_cell | 1.10925750 |
| 64 | MP0003828_pulmonary_edema | 1.10451996 |
| 65 | MP0003690_abnormal_glial_cell | 1.08960924 |
| 66 | MP0000598_abnormal_liver_morphology | 1.07567574 |
| 67 | MP0008469_abnormal_protein_level | 1.06349308 |
| 68 | MP0004043_abnormal_pH_regulation | 1.05205296 |
| 69 | MP0001756_abnormal_urination | 1.02052774 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.01289049 |
| 71 | MP0001851_eye_inflammation | 1.00144032 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.99323030 |
| 73 | MP0002006_tumorigenesis | 0.98154536 |
| 74 | MP0003300_gastrointestinal_ulcer | 0.97617116 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.97353994 |
| 76 | MP0009763_increased_sensitivity_to | 0.94242531 |
| 77 | MP0005647_abnormal_sex_gland | 0.93616260 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.89818319 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.89207653 |
| 80 | MP0000490_abnormal_crypts_of | 0.88008809 |
| 81 | MP0001873_stomach_inflammation | 0.87036670 |
| 82 | MP0003436_decreased_susceptibility_to | 0.86237762 |
| 83 | MP0006082_CNS_inflammation | 0.86188416 |
| 84 | MP0002009_preneoplasia | 0.85795891 |
| 85 | MP0003011_delayed_dark_adaptation | 0.85776296 |
| 86 | MP0001853_heart_inflammation | 0.84731214 |
| 87 | MP0009697_abnormal_copulation | 0.84271228 |
| 88 | MP0009379_abnormal_foot_pigmentation | 0.84031461 |
| 89 | MP0005408_hypopigmentation | 0.80421293 |
| 90 | MP0003075_altered_response_to | 0.79776505 |
| 91 | MP0009278_abnormal_bone_marrow | 0.77686605 |
| 92 | MP0010234_abnormal_vibrissa_follicle | 0.76993023 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.76853550 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.76788059 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.76414283 |
| 96 | MP0003724_increased_susceptibility_to | 0.76264298 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.75919188 |
| 98 | MP0003329_amyloid_beta_deposits | 0.75883508 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.74189709 |
| 100 | MP0005310_abnormal_salivary_gland | 0.73657730 |
| 101 | MP0004130_abnormal_muscle_cell | 0.73228686 |
| 102 | MP0005166_decreased_susceptibility_to | 0.72485075 |
| 103 | MP0005670_abnormal_white_adipose | 0.72082587 |
| 104 | MP0002971_abnormal_brown_adipose | 0.71632430 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.70305732 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.69632845 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.68589136 |
| 108 | MP0005535_abnormal_body_temperature | 0.68362790 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.67371673 |
| 110 | MP0005334_abnormal_fat_pad | 0.66519850 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.65692016 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.63423302 |
| 113 | MP0003303_peritoneal_inflammation | 0.62247028 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.61883396 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.60262528 |
| 116 | MP0003172_abnormal_lysosome_physiology | 0.59324841 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.58665931 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.58293618 |
| 119 | MP0001661_extended_life_span | 0.55450269 |
| 120 | MP0002419_abnormal_innate_immunity | 0.53223163 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.51561246 |
| 122 | MP0002928_abnormal_bile_duct | 0.51495442 |
| 123 | MP0000249_abnormal_blood_vessel | 0.51469752 |
| 124 | MP0005448_abnormal_energy_balance | 0.48635228 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.48037182 |
| 126 | MP0004947_skin_inflammation | 0.47396020 |
| 127 | MP0002796_impaired_skin_barrier | 0.47138968 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.46963107 |
| 129 | MP0008873_increased_physiological_sensi | 0.46750308 |
| 130 | MP0008004_abnormal_stomach_pH | 0.46065780 |
| 131 | MP0002168_other_aberrant_phenotype | 0.45793371 |
| 132 | MP0008874_decreased_physiological_sensi | 0.45604455 |
| 133 | MP0005266_abnormal_metabolism | 0.44644163 |
| 134 | MP0009053_abnormal_anal_canal | 0.44157014 |
| 135 | MP0005025_abnormal_response_to | 0.43916859 |
| 136 | MP0005164_abnormal_response_to | 0.42845204 |
| 137 | MP0009785_altered_susceptibility_to | 0.42273882 |
| 138 | MP0001881_abnormal_mammary_gland | 0.42261796 |
| 139 | MP0002135_abnormal_kidney_morphology | 0.41685016 |
| 140 | MP0001533_abnormal_skeleton_physiology | 0.41682939 |
| 141 | MP0000538_abnormal_urinary_bladder | 0.41347011 |
| 142 | MP0010155_abnormal_intestine_physiology | 0.41274373 |
| 143 | MP0009115_abnormal_fat_cell | 0.41066917 |
| 144 | MP0009384_cardiac_valve_regurgitation | 0.40152401 |
| 145 | MP0001663_abnormal_digestive_system | 0.39819056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.23681164 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.12962835 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.09149380 |
| 4 | Xanthomatosis (HP:0000991) | 5.73792946 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.61040489 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.21179730 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.16753637 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.93002307 |
| 9 | Complement deficiency (HP:0004431) | 4.78180769 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.63892010 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.56497760 |
| 12 | Myositis (HP:0100614) | 4.53915303 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.46369869 |
| 14 | Hyperammonemia (HP:0001987) | 4.25935425 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 4.23435403 |
| 16 | Orchitis (HP:0100796) | 4.18603538 |
| 17 | Hyperglycinuria (HP:0003108) | 4.14006451 |
| 18 | Joint hemorrhage (HP:0005261) | 4.10362091 |
| 19 | Ketosis (HP:0001946) | 4.02555289 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.96394399 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.93348568 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.90174250 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90174250 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85860126 |
| 25 | Epidermoid cyst (HP:0200040) | 3.82146875 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.81807999 |
| 27 | Optic neuritis (HP:0100653) | 3.81807999 |
| 28 | Hyperglycinemia (HP:0002154) | 3.80004232 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.79221810 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.73068810 |
| 31 | Fat malabsorption (HP:0002630) | 3.72880655 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.69095288 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.65022706 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.64073809 |
| 35 | Abnormality of complement system (HP:0005339) | 3.55060744 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.49691700 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 3.45514772 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.42772285 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.37253015 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34999890 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.30166756 |
| 42 | Gout (HP:0001997) | 3.29484281 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.25841471 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.23627679 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22876018 |
| 46 | Obstructive lung disease (HP:0006536) | 3.22876018 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 3.20734343 |
| 48 | Encephalitis (HP:0002383) | 3.18898495 |
| 49 | Meningitis (HP:0001287) | 3.14197331 |
| 50 | Ketoacidosis (HP:0001993) | 3.11221775 |
| 51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11165669 |
| 52 | Stomatitis (HP:0010280) | 3.08004200 |
| 53 | Recurrent fungal infections (HP:0002841) | 3.05866777 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04850101 |
| 55 | Vasculitis (HP:0002633) | 3.00227101 |
| 56 | Recurrent skin infections (HP:0001581) | 2.98517952 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.96377007 |
| 58 | Vascular calcification (HP:0004934) | 2.96300643 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.94535449 |
| 60 | Abnormality of the intrinsic pathway (HP:0010989) | 2.94094519 |
| 61 | Chronic diarrhea (HP:0002028) | 2.92252726 |
| 62 | Gingivitis (HP:0000230) | 2.90803297 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.89334020 |
| 64 | Myocardial infarction (HP:0001658) | 2.89232917 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.88695261 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.88079641 |
| 67 | Malnutrition (HP:0004395) | 2.83407334 |
| 68 | Pulmonary embolism (HP:0002204) | 2.81791447 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.79908258 |
| 70 | Epistaxis (HP:0000421) | 2.78316062 |
| 71 | Metabolic acidosis (HP:0001942) | 2.76519586 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.75338592 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.74413169 |
| 74 | Abnormality of proline metabolism (HP:0010907) | 2.72991718 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.72991718 |
| 76 | Glomerulonephritis (HP:0000099) | 2.72841592 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.69466059 |
| 78 | Steatorrhea (HP:0002570) | 2.67299464 |
| 79 | Urticaria (HP:0001025) | 2.65703694 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.64389397 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.63804203 |
| 82 | Hemoptysis (HP:0002105) | 2.63678958 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62098165 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60151845 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60151845 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.57912187 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.57021122 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57021122 |
| 89 | Arterial thrombosis (HP:0004420) | 2.51372873 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.51183729 |
| 91 | Chest pain (HP:0100749) | 2.50143441 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.50077602 |
| 93 | Pustule (HP:0200039) | 2.47714308 |
| 94 | Spastic diplegia (HP:0001264) | 2.45754923 |
| 95 | Skin nodule (HP:0200036) | 2.45587101 |
| 96 | Purpura (HP:0000979) | 2.44227235 |
| 97 | Anorexia (HP:0002039) | 2.43823378 |
| 98 | Proximal tubulopathy (HP:0000114) | 2.42043493 |
| 99 | Petechiae (HP:0000967) | 2.41646681 |
| 100 | Esophageal varix (HP:0002040) | 2.40602066 |
| 101 | Gangrene (HP:0100758) | 2.38506494 |
| 102 | Alkalosis (HP:0001948) | 2.37928087 |
| 103 | Amyloidosis (HP:0011034) | 2.37816202 |
| 104 | Inflammation of the large intestine (HP:0002037) | 2.35763917 |
| 105 | Abnormality of T cell number (HP:0011839) | 2.34069095 |
| 106 | Joint swelling (HP:0001386) | 2.33576995 |
| 107 | Lethargy (HP:0001254) | 2.30938411 |
| 108 | Hypochromic anemia (HP:0001931) | 2.27977298 |
| 109 | Axonal loss (HP:0003447) | 2.26931006 |
| 110 | Hyperuricemia (HP:0002149) | 2.26611873 |
| 111 | Increased purine levels (HP:0004368) | 2.26611873 |
| 112 | T lymphocytopenia (HP:0005403) | 2.25350052 |
| 113 | Irritability (HP:0000737) | 2.24615380 |
| 114 | Glycosuria (HP:0003076) | 2.24596558 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 2.24596558 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.22977320 |
| 117 | Peritonitis (HP:0002586) | 2.22513072 |
| 118 | Abnormality of T cells (HP:0002843) | 2.21886131 |
| 119 | Rickets (HP:0002748) | 2.21569493 |
| 120 | Mitral stenosis (HP:0001718) | 2.20319180 |
| 121 | Pancreatitis (HP:0001733) | 2.19442067 |
| 122 | Recurrent viral infections (HP:0004429) | 2.18677469 |
| 123 | Leukocytosis (HP:0001974) | 2.18036003 |
| 124 | Increased serum ferritin (HP:0003281) | 2.17130478 |
| 125 | Vacuolated lymphocytes (HP:0001922) | 2.16661721 |
| 126 | Granulocytopenia (HP:0001913) | 2.16558497 |
| 127 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.15853537 |
| 128 | Late onset (HP:0003584) | 2.15010418 |
| 129 | Abnormality of the pleura (HP:0002103) | 2.14979272 |
| 130 | Abnormality of T cell physiology (HP:0011840) | 2.14486632 |
| 131 | Spontaneous abortion (HP:0005268) | 2.14075104 |
| 132 | Vomiting (HP:0002013) | 2.13680402 |
| 133 | Osteomyelitis (HP:0002754) | 2.13676991 |
| 134 | Skin rash (HP:0000988) | 2.12867729 |
| 135 | Acanthocytosis (HP:0001927) | 2.12788179 |
| 136 | Cellulitis (HP:0100658) | 2.11447923 |
| 137 | Episodic fever (HP:0001954) | 2.10976000 |
| 138 | Polycythemia (HP:0001901) | 2.10765544 |
| 139 | Nephritis (HP:0000123) | 2.10360515 |
| 140 | Colitis (HP:0002583) | 2.10074853 |
| 141 | Neonatal onset (HP:0003623) | 2.06948005 |
| 142 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06737713 |
| 143 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06737713 |
| 144 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06737713 |
| 145 | Hemorrhage of the eye (HP:0011885) | 2.04529135 |
| 146 | Widely patent fontanelles and sutures (HP:0004492) | 2.04087644 |
| 147 | Hypoglycemic seizures (HP:0002173) | 2.04060356 |
| 148 | Gingival bleeding (HP:0000225) | 2.02521463 |
| 149 | Cholecystitis (HP:0001082) | 1.98857896 |
| 150 | Abnormal gallbladder physiology (HP:0012438) | 1.98857896 |
| 151 | Increased IgE level (HP:0003212) | 1.98149373 |
| 152 | Menorrhagia (HP:0000132) | 1.97386311 |
| 153 | Glomerulopathy (HP:0100820) | 1.96499064 |
| 154 | Abnormal gallbladder morphology (HP:0012437) | 1.96364482 |
| 155 | Panhypogammaglobulinemia (HP:0003139) | 1.95642283 |
| 156 | Poikilocytosis (HP:0004447) | 1.95627511 |
| 157 | Dysostosis multiplex (HP:0000943) | 1.94954711 |
| 158 | Cholelithiasis (HP:0001081) | 1.94801927 |
| 159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.94098659 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92042565 |
| 161 | Abnormal cartilage morphology (HP:0002763) | 1.91619220 |
| 162 | Increased IgM level (HP:0003496) | 1.91314427 |
| 163 | Elevated alkaline phosphatase (HP:0003155) | 1.90547763 |
| 164 | Nephrolithiasis (HP:0000787) | 1.90422775 |
| 165 | Hypochromic microcytic anemia (HP:0004840) | 1.86456874 |
| 166 | Nausea (HP:0002018) | 1.85842169 |
| 167 | Enlarged kidneys (HP:0000105) | 1.84821204 |
| 168 | Thrombophlebitis (HP:0004418) | 1.82390473 |
| 169 | Hypophosphatemic rickets (HP:0004912) | 1.81945238 |
| 170 | Abnormality of iron homeostasis (HP:0011031) | 1.79451463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.84265837 |
| 2 | ERN1 | 4.15598137 |
| 3 | FGFR4 | 3.31653385 |
| 4 | ACVR1B | 3.18296465 |
| 5 | SIK1 | 3.16646352 |
| 6 | MST1R | 3.02844436 |
| 7 | TAOK3 | 2.72848979 |
| 8 | TRIB3 | 2.57257827 |
| 9 | TXK | 2.42514401 |
| 10 | FES | 2.39980334 |
| 11 | IRAK4 | 2.28487957 |
| 12 | EPHB1 | 2.16712316 |
| 13 | PKN2 | 2.13944608 |
| 14 | PRPF4B | 1.92254164 |
| 15 | ERBB4 | 1.89983908 |
| 16 | TYK2 | 1.87158726 |
| 17 | WNK4 | 1.83967667 |
| 18 | PTK6 | 1.83780795 |
| 19 | FRK | 1.77070065 |
| 20 | SYK | 1.75645287 |
| 21 | INSRR | 1.71533976 |
| 22 | BMPR2 | 1.71163741 |
| 23 | GRK6 | 1.63803361 |
| 24 | TGFBR2 | 1.62987830 |
| 25 | TBK1 | 1.58137250 |
| 26 | MATK | 1.52134209 |
| 27 | MAP3K14 | 1.49139792 |
| 28 | HCK | 1.47424151 |
| 29 | IRAK3 | 1.46252929 |
| 30 | FGR | 1.45543394 |
| 31 | LYN | 1.44438491 |
| 32 | TEC | 1.41243651 |
| 33 | PIK3CG | 1.37830558 |
| 34 | RIPK1 | 1.30951043 |
| 35 | NEK9 | 1.30751447 |
| 36 | MAPK11 | 1.23961717 |
| 37 | JAK1 | 1.22175269 |
| 38 | JAK2 | 1.21565906 |
| 39 | CAMK1D | 1.20138373 |
| 40 | YES1 | 1.19011198 |
| 41 | MET | 1.18626519 |
| 42 | OXSR1 | 1.18291884 |
| 43 | LCK | 1.17763460 |
| 44 | ABL2 | 1.15638874 |
| 45 | MAP3K10 | 1.12716829 |
| 46 | TNK2 | 1.12582031 |
| 47 | CSK | 1.08410407 |
| 48 | MAP3K2 | 1.08354573 |
| 49 | MAP2K4 | 1.07680647 |
| 50 | TESK2 | 1.07271727 |
| 51 | PRKAA2 | 1.06451664 |
| 52 | IRAK1 | 1.04160242 |
| 53 | MAP3K6 | 1.03904888 |
| 54 | DAPK2 | 1.03830359 |
| 55 | FGFR2 | 1.03202846 |
| 56 | MAP2K3 | 1.02816131 |
| 57 | LATS1 | 1.00665021 |
| 58 | MAP3K7 | 1.00515709 |
| 59 | MAP3K3 | 0.99232509 |
| 60 | BLK | 0.98972661 |
| 61 | FLT3 | 0.97123793 |
| 62 | MAP3K12 | 0.96857699 |
| 63 | IKBKB | 0.93467953 |
| 64 | BMX | 0.91904456 |
| 65 | PDPK1 | 0.88975785 |
| 66 | GSK3A | 0.88954060 |
| 67 | PBK | 0.88599338 |
| 68 | TAOK1 | 0.87256724 |
| 69 | MAP2K2 | 0.86466561 |
| 70 | GRK7 | 0.85758559 |
| 71 | STK39 | 0.84791325 |
| 72 | LMTK2 | 0.82327569 |
| 73 | LRRK2 | 0.81233886 |
| 74 | MAP3K13 | 0.80115468 |
| 75 | IKBKE | 0.78177967 |
| 76 | MAPK15 | 0.77266312 |
| 77 | MAP4K1 | 0.76525462 |
| 78 | CDK19 | 0.75441340 |
| 79 | PTK2 | 0.75348335 |
| 80 | MARK3 | 0.73456582 |
| 81 | CAMK1G | 0.73373787 |
| 82 | MAP3K5 | 0.71018246 |
| 83 | MAP3K11 | 0.70916906 |
| 84 | WNK3 | 0.69567760 |
| 85 | MAP2K6 | 0.69302412 |
| 86 | KDR | 0.69290517 |
| 87 | SGK3 | 0.69253748 |
| 88 | PIM1 | 0.68898907 |
| 89 | CDK6 | 0.68441769 |
| 90 | TIE1 | 0.68227459 |
| 91 | KSR2 | 0.66182498 |
| 92 | PRKG2 | 0.65533721 |
| 93 | MAPK4 | 0.65493951 |
| 94 | FYN | 0.63078197 |
| 95 | PRKCZ | 0.62287024 |
| 96 | NLK | 0.61876152 |
| 97 | CSF1R | 0.61714643 |
| 98 | FGFR3 | 0.59916014 |
| 99 | SIK3 | 0.59472116 |
| 100 | PDK1 | 0.57725532 |
| 101 | IRAK2 | 0.57291938 |
| 102 | MAPK12 | 0.57046878 |
| 103 | DYRK1B | 0.56698540 |
| 104 | MAP3K1 | 0.55899438 |
| 105 | PINK1 | 0.55342981 |
| 106 | TRPM7 | 0.55162548 |
| 107 | PRKACG | 0.54981505 |
| 108 | ERBB2 | 0.54340625 |
| 109 | MST4 | 0.53015366 |
| 110 | STK38L | 0.52797073 |
| 111 | PRKCQ | 0.52316338 |
| 112 | CAMKK2 | 0.51570126 |
| 113 | PIK3CA | 0.49256121 |
| 114 | RET | 0.48964439 |
| 115 | EPHA3 | 0.48899877 |
| 116 | MYLK | 0.47928876 |
| 117 | ZAP70 | 0.47016443 |
| 118 | MAPKAPK2 | 0.45983202 |
| 119 | EGFR | 0.45927124 |
| 120 | MAP2K1 | 0.45046283 |
| 121 | SGK223 | 0.44873933 |
| 122 | SGK494 | 0.44873933 |
| 123 | KIT | 0.44434167 |
| 124 | PRKAA1 | 0.44229598 |
| 125 | TAOK2 | 0.44014861 |
| 126 | RIPK4 | 0.43433350 |
| 127 | PRKCD | 0.43391318 |
| 128 | BTK | 0.42179227 |
| 129 | CAMK2G | 0.41064102 |
| 130 | IGF1R | 0.40486769 |
| 131 | PDGFRA | 0.40428063 |
| 132 | JAK3 | 0.40327621 |
| 133 | STK10 | 0.38468280 |
| 134 | ICK | 0.38207210 |
| 135 | PDK2 | 0.36935382 |
| 136 | ITK | 0.36843447 |
| 137 | ABL1 | 0.36746332 |
| 138 | HIPK2 | 0.33237090 |
| 139 | MAPK7 | 0.28902575 |
| 140 | RPS6KC1 | 0.28786274 |
| 141 | RPS6KL1 | 0.28786274 |
| 142 | CDC42BPA | 0.26131683 |
| 143 | PRKD2 | 0.26054651 |
| 144 | RPS6KA6 | 0.25596125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.93967150 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.52230735 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41460973 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93111523 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71892625 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65101184 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62921188 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60656363 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.50747682 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49259061 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48709222 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38469812 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38223012 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31119195 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.27516198 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21392670 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.19359260 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.13571484 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06612977 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.04857854 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03631301 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00749467 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.99126683 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.98480273 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89544680 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81671335 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81617499 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80565275 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78297415 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77900387 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72903606 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71507782 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71198176 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.68555673 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67797123 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66250143 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66187520 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59751964 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56655789 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51293104 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46633670 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45295853 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.45165562 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45079398 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44368440 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43890694 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40678340 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39622292 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35081471 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34057925 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31040428 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30711858 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26239403 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24574039 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24255772 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22937486 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21707007 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.19099159 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18030529 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16060990 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14681920 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10365370 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07911249 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03689863 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02661836 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02179179 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00345616 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 0.99349845 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99279853 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98772471 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96862701 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92764425 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92740222 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.91545355 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89208697 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87093513 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86321546 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.85609080 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85602641 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.85529081 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.82895255 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82507017 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81150283 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80733719 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80412861 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79293234 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78616836 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76616433 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75329957 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75318471 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74436579 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72260605 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70886757 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70356823 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69822699 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67525615 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66219104 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.65663939 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58424426 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57134951 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56105743 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54211762 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53612440 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49470961 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.42554971 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.42195036 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42006712 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39725037 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39049347 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37683820 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36739672 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.35190567 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35055388 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34942466 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.34264693 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.32787364 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32118539 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31857706 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.28756689 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.28673113 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28488427 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28251867 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28142738 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25087643 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18455988 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15611088 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12861074 |
| 128 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07759358 |
| 129 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03863611 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02245835 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00166073 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00075089 |
| 133 | Malaria_Homo sapiens_hsa05144 | -0.1274579 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1266510 |
| 135 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1068344 |
| 136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0707028 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | -0.0686956 |
| 138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0655764 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0618982 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0491775 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0484983 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0358979 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | -0.0239075 |
| 144 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0145932 |
| 145 | Pertussis_Homo sapiens_hsa05133 | -0.0015946 |

